tiprankstipranks

Robert K Zeldin Insider Profile

4 Followers
Robert K Zeldin, EVP & Chief Medical Officer at Acceleron Pharma, holds 19.10K shares in Acceleron Pharma (Ticker: XLRN), holds ― shares in Immunovant (Ticker: IMVT), holds 89.72K shares in Meiragtx Holdings (Ticker: MGTX).
tipranks
Robert K Zeldin

Robert K Zeldin
Acceleron Pharma (XLRN)
EVP & Chief Medical Officer

Not Ranked
Robert K Zeldin has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$438K
100.00%
0.00%
A breakdown of Robert K Zeldin's holdings

Insider Roles

Meiragtx Holdings
(MGTX)
CMO
Immunovant
(IMVT)
Chief Medical Officer
Roles that Robert K Zeldin holds in companies

Most Profitable Insider Trade

Stock:
Meiragtx Holdings
(MGTX)
Rating:Informative Buy
Date:Jun 06, 2022 - Jun 06, 2023
Return:-3.80%
The most profitable trade made by Robert K Zeldin

Robert K Zeldin's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
XLRN
Acceleron Pharma
Jan 29, 2019
Uninformative Buy
$3.41M
Immunovant
Chief Medical Officer
Meiragtx Holdings
Jan 17, 2024
CMO
Uninformative Buy
93.85K
$437.85K
List of latest transactions for each holding click on a transaction to see Robert K Zeldin's performance on stock

Robert K Zeldin insider profile FAQ

What is the percentage of profitable transactions made by Robert K Zeldin?
The percentage of profitable transactions made by Robert K Zeldin is ―.
    What is the average return per transaction made by Robert K Zeldin?
    The average return per transaction made by Robert K Zeldin is ―.
      What stocks does Robert K Zeldin hold?
      Robert K Zeldin holds: XLRN, IMVT, MGTX stocks.
        What was Robert K Zeldin’s latest transaction?
        Robert K Zeldin latest transaction was an Uninformative Buy of ―.
          What was Robert K Zeldin's most profitable transaction?
          Robert K Zeldin’s most profitable transaction was an Informative Buy of MGTX stock on June 6, 2022. The return on the trade was -3.80%.
            What is Robert K Zeldin's role in Acceleron Pharma?
            Robert K Zeldin's role in Acceleron Pharma is EVP & Chief Medical Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.